A comparison of delayed bleeding associated with endoscopic submucosal dissection for gastric neoplasms between solid and liquid diet

A comparison of delayed bleeding associated with endoscopic submucosal dissection for gastric neoplasms between solid and liquid diet - ESD Asahi Trial (EAT)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013297

Enrollment

100

Registered

2014-03-01

Start date

2014-02-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early gastric cancer, gastric adenoma

Interventions

solid diet liquid diet

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with gastric neoplasms who underwent ESD

Exclusion criteria

Exclusion criteria: (1)patients with use of antiplatelet agents(aspirin, thienopyridine derivative,and cilostazol) and anticoagulants (2) patients who are pregnant or nursing (3) patients with unstable mental condition (4) patients with use of steroid drugs (5) patients with bacterial and fungal infection (6) patients who are diagnosed as unsuitable for this trial by investigator

Design outcomes

Primary

Measure	Time frame
delayed bleeding rate	—

Secondary

Measure	Time frame
1.the rate of ulcer scar about 4 weeks after ESD(evaluate by Sakita classification) 2.the QOL changing between the date of admission and leave the hospital(evaluate by EORTC QLQ-C30 and EORTC QLQ-STO 22) 3.hospital charges 4.abdominal distension 5.abdominal pain 6.constipation 7.diarrhea 8.nausea	—

Countries

Japan

Contacts

Public ContactAkihiro Miyakawa

Asahi General Hospital Department of Gastroenterology

a292miyaka2007@yahoo.co.jp0479-63-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026